The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Interested in all sessions Cellular Therapy/Biotherapies? Then this is the package for you. We have also thrown in a couple of additional sessions you might also find interesting…
By far the best value to watch all the on-demand educational sessions from the 2024 AABB Annual Meeting and earn continuing education credit…
CABP CE Eligible
In this comprehensive session, we delve into the pivotal role of artificial intelligence (AI) in revolutionizing lab staff competency assessments within cell processing facilities and blood banks, directly addressing AABB's stringent competency requirements. Our focus extends to the meticulous adherence to standards C 2.1.6 and its critical subsections, outlining a systematic approach to leveraging AI for enhancing the evaluation process. We commence by dissecting the AABB standards for competency, emphasizing the necessity of evaluations prior to independent task performance and the annual as well as semi-annual review mechanisms. Highlighting the regulatory backdrop, including 42 CFR 493.1413(b)(8) and (b)(9) among others, we set the stage for understanding the imperative of these evaluations in ensuring compliance and enhancing operational excellence. The session transitions into a deep dive into the AI methodologies that can be deployed for competency assessments. From machine learning algorithms that predict performance outcomes to virtual reality simulations for hands-on experience without risk, attendees will explore a spectrum of AI tools. These tools not only streamline the evaluation process but also introduce a level of precision and adaptability previously unattainable with traditional methods. Practical case studies will serve as the cornerstone of this session, offering real-world insights into successful AI integration within lab settings. These studies will underscore the challenges faced, solutions implemented, and the impact on competency assessment processes. Additionally, expert-led discussions will furnish attendees with actionable strategies for adopting AI within their facilities, ensuring both alignment with AABB standards and a significant uplift in staff competency levels. By the end of this session, participants will be equipped with the knowledge to critically assess their current competency evaluation processes, identify areas ripe for AI integration, and initiate steps toward a more efficient, effective, and compliant assessment framework. Attendees will leave with a clear roadmap for harnessing AI's potential to meet and exceed AABB standards, thereby elevating their facility's competency and service quality to new heights.
Learning Objectives
Understand the current AABB standards for competency evaluations in cell processing facilities and blood banks.
Identify challenges in traditional competency assessment methods and how AI can address these gaps.
Explore AI tools and technologies currently available for competency assessment in laboratory settings.
Develop strategies for integrating AI into competency evaluation processes to meet AABB standards.
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
AM24-ST-20-O: Enhancing Laboratory Competency with AI: Meeting AABB Standards for Cell Processing Facilities and Blood Banks (Enduring) Evaluation
The Biotherapies Spotlight Session will cover several diverse topics. The use of controlled incremental filtration microfluidics rather than monoclonal antibody selection systems to isolate B-cells from whole blood will be discussed…
Decentralized manufacturing has become a prominent focus in the Advanced Therapies space as the number of therapies in development increases and patient volumes surge with earlier line treatment objectives…
This session equips blood bank, transfusion medicine, and biotherapies professionals with practical tools for robust risk assessment. Risk identification methods and customizing risk registers for specific practice areas will be covered…
Hematopoietic stem cells (HSCs) are the apex hematopoietic cell with the potential to produce robust and lifelong production of all blood cells. Thus, understanding the details of HSC molecular biology is critical to our understanding of human health and longevity…